Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A3 | O15427 | 11/20 | 0.82 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.73 |
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
| ▸ | AKT2 | P31751 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21565599 | 1.00 | SLC16A3 (0.82) | SLC16A3KCNH2AKT1AKT2KDM4E | |
| SCHEMBL23116352 | 1.00 | SLC16A3 (0.82) | SLC16A3KCNH2AKT1AKT2KDM4E | |
| SCHEMBL21565501 | 1.00 | SLC16A3 (0.82) | SLC16A3KCNH2AKT1AKT2KDM4E | |
| SCHEMBL21565591 | 0.92 | SLC16A3 (0.77) | SLC16A3KCNH2AKT1AKT2KDM4E | |
| SCHEMBL23116272 | 0.92 | SLC16A3 (0.77) | SLC16A3KCNH2AKT1AKT2KDM4E | |
| SCHEMBL23116300 | 0.92 | SLC16A3 (0.77) | SLC16A3KCNH2AKT1AKT2KDM4E | |
| SCHEMBL21565583 | 0.92 | SLC16A3 (0.77) | SLC16A3KCNH2AKT1AKT2KDM4E | |
| SCHEMBL21550842 | 0.90 | SLC16A3 (1.00) | SLC16A3KCNH2AKT1AKT2 | |
| SCHEMBL21550845 | 0.90 | SLC16A3 (1.00) | SLC16A3KCNH2AKT1AKT2 | |
| SCHEMBL23116275 | 0.89 | SLC16A3 (0.83) | SLC16A3KCNH2AKT1AKT2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3790879-B1 | TRIAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2022-06-29 | — | — | EP | disclosed |